Leo Pharma starts study of eczema tablet for nettle rash
Leo Pharma and JW Therapeutics have started a new clinical trial in Germany, testing a tablet that was originally developed for eczema on nettle rash.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Leo Pharma has started expanding the potential span of the eczema tablet which it bought from Korean firm JW Therapeutics in 2018.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Incyte's atopical dermatitis cream delayed
For subscribers
Ascendis increases expenses shortly before moment of truth
For subscribers
.jpg&w=384&q=75)
